advanced search

INJECTION

EMERGING TRENDS IN WEARABLE DRUG DELIVERY
WEARABLES
Tony Bedford
Phillips Medisize
EMERGING TRENDS IN WEARABLE DRUG DELIVERY
Tony Bedford discusses the current state of the fledgling on-body injector market, including the difficulties of competing with autoinjectors in the <5 mL space, the potential on-body injectors have in oncology and Phillips-Medisize’s own developments in the on-body injector field.
SIMPLIFYING LARGE-VOLUME PATCH INJECTION FOR PHARMA AND PATIENTS
WEARABLES
Reto Jost
Ypsomed
SIMPLIFYING LARGE-VOLUME PATCH INJECTION FOR PHARMA AND PATIENTS
Reto Jost provides an update on the YpsoDose platform and its importance as the driver for the business unit’s new patch injector franchise.
THE NEW PATIENT-CENTRICITY
WEARABLES
Jennifer Estep
Enable Injections
THE NEW PATIENT-CENTRICITY
Jennifer Estep discusses the new pressures put on the healthcare system by the covid-19 pandemic, and how patients and healthcare providers alike are turning to patient-centric solutions to minimise risks and ease burdens.
TECHNOLOGY SHOWCASE: CCBio’s QuickDose
WEARABLES
Jimmy Fan
CC Bio
TECHNOLOGY SHOWCASE: CCBio’s QuickDose
CCBio is introducing a new era of wearable on-body medical devices. QuickDose, recently successfully developed with both patients and pharmaceutical industry partners in mind, contains all the necessary elements for an excellent on-body device, comprising three major technical achievements.
OPTIMA COVID-19 VACCINE FILLING SYSTEM DELIVERED TO CATALENT IN THE US
OPTIMA COVID-19 VACCINE FILLING SYSTEM DELIVERED TO CATALENT IN THE US
Optima has delivered a second vial filling system to Catalent's biologics facility in Bloomington, IN, US, to be used initially for the filling of a vaccine candidate to fight covid-19 (SARS-CoV-2).
FROM FORMULATION TO MANUFACTURING: LIPID NANOPARTICLE mRNA VACCINES, GENE THERAPIES & OTHER NANOMEDICINES
INDUSTRIALISATION
Stephen Allan
Evonik
FROM FORMULATION TO MANUFACTURING: LIPID NANOPARTICLE mRNA VACCINES, GENE THERAPIES & OTHER NANOMEDICINES
Stephen Allan reviews the history and formulation advantages of lipid nanoparticles (LNPs) and addresses factors that should be considered by pharmaceutical companies during the CDMO selection process to help reduce regulatory risk, improve product performance and accelerate speed to market.
CUSTOMISING PLATFORM DEVICES: CHALLENGES & CONSIDERATIONS
INDUSTRIALISATION
Doug Boyd
CUSTOMISING PLATFORM DEVICES: CHALLENGES & CONSIDERATIONS
How do you choose the best delivery system for your drug? Doug Boyd explores the pros and cons of a cost-effective, off-the-shelf platform versus a custom drug delivery device, and discusses the challenges and considerations of customising an existing platform device.
MEETING QUALITY DEMANDS THROUGH INTEGRATED PRODUCTS & SERVICES
INDUSTRIALISATION
Lars Keinicke Hansen
Stevanato Group
MEETING QUALITY DEMANDS THROUGH INTEGRATED PRODUCTS & SERVICES
Lars Keinicke Hansen; Chiara Mussoi and Odra Pinato describe how the streamlining of processes and harmonisation of products and services can better serve pharmaceutical companies. A case study highlights how a unique combination of expertise in automation and glass primary packaging benefited pharma giant Merck Serono in a recent project.
INTEGRATING DESIGN AND INDUSTRIALISATION TO OPTIMISE COST, QUALITY & TIME
INDUSTRIALISATION
Pete Evans
SMC Ltd
INTEGRATING DESIGN AND INDUSTRIALISATION TO OPTIMISE COST, QUALITY & TIME
Pete Evans and Meredith Canty explore how integrating design and industrialisation teams can optimise the cost, quality and time of developing a novel drug delivery system.
MEETING DEMAND BY BRINGING MANUFACTURING IN-HOUSE
INDUSTRIALISATION
Bentsi Algazi
Eitan Medical
MEETING DEMAND BY BRINGING MANUFACTURING IN-HOUSE
Bentsi Algazi and Anna Kalika-Rodin discuss the process of developing and implementing in-house production facilities at Sorrel Medical, including cleanroom facilities. The authors discuss the regulatory requirements involved, practical considerations of the design and construction, and the benefits the establishment of in-house facilities confers to Sorrel and its pharmaceutical partners.
APPLICATIONS OF DEEP LEARNING IN MEDICAL DEVICE MANUFACTURING
INDUSTRIALISATION
Frederick Gertz
SHL Medical
APPLICATIONS OF DEEP LEARNING IN MEDICAL DEVICE MANUFACTURING
Frederick Gertz and Gilbert Fluetsch look at how deep learning can be leveraged in a medical device manufacturing environment.
THE FUTURE OF SMART FILL-AND-FINISH
INDUSTRIALISATION
Diana Löber
SCHOTT Pharma
THE FUTURE OF SMART FILL-AND-FINISH
Diana Löber discusses new developments in digitised pharmaceutical manufacturing and the role SCHOTT’s Smart Containers can play in traceability along the entire value chain.
THE AWARD-WINNING CREDENCE CONNECT™ AUTO-SENSING INJECTION SYSTEM
CONNECTIVITY
John Merhige
Credence MedSystems
THE AWARD-WINNING CREDENCE CONNECT™ AUTO-SENSING INJECTION SYSTEM
John Merhige explains how connectivity that is universally applicable to any existing prefilled syringe platform adds value throughout the ecosystem, both including and beyond the “compliance business model”.
POLYMERIC EMI SHIELDING: PROVIDING A MORE SECURE FUTURE FOR PATIENTS
CONNECTIVITY
Marnik Vaes
POLYMERIC EMI SHIELDING: PROVIDING A MORE SECURE FUTURE FOR PATIENTS
Marnik Vaes, Leen-Pieter Deurloo and Martin Sas discuss the role of polymeric electromagnetic interference shielding in providing a more secure future for patients in a connected world.
SENSORS ARE TOOLS – BUT HOW DO YOU MAKE THEM SMART?
CONNECTIVITY
Gaël Senée
Biocorp
SENSORS ARE TOOLS – BUT HOW DO YOU MAKE THEM SMART?
Gaël Senée and Arnaud Guillet explore the benefits of Mallya – a smart sensor that turns conventional injection pens into connected devices. They also discuss the crucial role Biocorp’s connected prefilled syringe, Injay, could play in future COVID-19 vaccination programmes.
APPLYING CONNECTIVITY TO ENHANCE THE TRAINING STANDARD OF CARE FOR SELF-INJECTION
CONNECTIVITY
Erin Miller
Noble
APPLYING CONNECTIVITY TO ENHANCE THE TRAINING STANDARD OF CARE FOR SELF-INJECTION
Erin Miller looks at how connectivity can be used to enhance training to help address the challenges of accuracy and non-adherence when patients self-inject their medications.
INTERVIEW WITH SAI SHANKAR, ADAM SHAIN & MARCUS BATES
INTERVIEW
Sai Shankar
Aptar Pharma
INTERVIEW WITH SAI SHANKAR, ADAM SHAIN & MARCUS BATES
Sai Shankar, Adam Shain and Marcus Bates discuss the full potential of connectivity, coronavirus as a potential accelerator of adoption, and the place of connected drug delivery systems within Aptar Pharma’s broader offering to industry.
MEETING THE CHALLENGES OF COVID-19
CONNECTIVITY
Beo Arana de Martinez
MEETING THE CHALLENGES OF COVID-19
Beo Arana de Martinez and Ilan Shopen discuss the effects of the covid-19 pandemic on patient populations, how the healthcare industry has intensified activity to fight the virus, and how connected devices that facilitate self-injection and remote monitoring are coming into their own.
UNLOCKING INSIGHT FOR PATIENT SUPPORT PROGRAMMES
CONNECTIVITY
Neil Williams
Phillips Medisize
UNLOCKING INSIGHT FOR PATIENT SUPPORT PROGRAMMES
Neil Williams and Andrew Tubb discuss how insights delivered by a cloud-based connected health system help patient support programmes to monitor and improve medication adherence.
CONNECTED DEVICE DATA NEEDED TO MAKE HOME CARE THE STANDARD
EXPERT VIEW
Dr Andrei Yosef
CONNECTED DEVICE DATA NEEDED TO MAKE HOME CARE THE STANDARD
With home care on the increase as a result of the coronavirus pandemic, Andrei Yosef looks at the crucial role played by connected home care medical devices and the data they generate.
EPIWATCH: A NOVEL LIFE-SAVING MICRO AUTOINJECTOR IN A SMART WATCH
EARLY INSIGHT
Amber Witteman
EPIWATCH: A NOVEL LIFE-SAVING MICRO AUTOINJECTOR IN A SMART WATCH
Amber Witteman, Thijs Roebers and Dirk-Jan Opstelten introduce the company’s patented innovation, a wearable autoinjector customised to fit the wrist.
Adding value to Drug Delivery with Connectivity
VIDEO
Kevin Deane
Phillips Medisize
Adding value to Drug Delivery with Connectivity
In this video presentation, Kevin Deane looks at how connectivity applied in drug delivery technologies can provide better solutions for patients and for industry and add value for all stakeholders.
ESTABLISHING DATA-DRIVEN DESIGN AND MANUFACTURING FOR MEDICAL DEVICES
INJECTION
Frederick Gertz
SHL Medical
ESTABLISHING DATA-DRIVEN DESIGN AND MANUFACTURING FOR MEDICAL DEVICES
Frederick Gertz explores the benefits for medical device design and manufacturing organisations of adapting to the use of big data and analytics.
INTERVIEW WITH STEVEN KAUFMAN, STEVANATO & URI BARUCH, CDP
INTERVIEW
Steven Kaufman
Stevanato Group
INTERVIEW WITH STEVEN KAUFMAN, STEVANATO & URI BARUCH, CDP
Steven Kaufman and Uri Baruch discuss the recently announced collaboration between their two companies to accelerate the development of a new variable-dose, cartridge-based pen injector platform for diabetes.
Top